Aethlon Medical continues to observe directional changes in second cohort of Australian oncology clinical trial evaluating Hemopurifier: San Diego Tuesday, July 14, 2026, 18:00 Hr ...
INSIGHT-003 demonstrates mature mOS of 30.9 months in both the overall population (N=51) and patients with TPS <50% (N=47) in 1L non-squamous ...
A new study published in the journal of BMC Pulmonary Medicine showed that some children with asthma continued to have a ...
Aethlon Medical (Nasdaq: AEMD) reports the second cohort of its Australian oncology feasibility study showed directional ...
The influencer, 26, is currently in between stages of a clinical trial involving tumor-infiltrating lymphocyte therapy ...
5d
Iovance Biotherapeutics (IOVA) Updates its Corporate Presentation, Here’s What’s Important to Note
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the Best Penny Stocks to Invest In According to Billionaires. Recently, ...
Global News on MSN
Etobicoke father fighting bureaucratic battle to access cancer treatment
Alex Shved has stage 4 cancer and is fighting the Ontario government to get potentially lifesaving treatment called ...
Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today announced the grant of a new patent (number 12,673,088) entitled ...
New Hodgkin lymphoma recommendations emphasise PET guided and risk adapted treatment strategies across disease stages.
Sellas Life Sciences stock faces downside risk ahead of REGAL Phase 3 data, and the valuation looks stretched. Click here to ...
Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...
The Canadian Press on MSN
Toronto man seeks answers on cancer therapy denial
A 37-year-old Toronto man with stage 4 melanoma is searching for answers on why his application for funding under Ontario's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results